Cynosure Expands Best-In-Class Potenza™ RF Microneedling System

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Cynosure announced today the U.S. launch of its one-of-a-kind Fusion Tip, the newest addition to its best-in-class Potenza™ radiofrequency (RF) microneedling system.

With its dual-air chamber design, the Fusion Tip captures and releases air towards the skin with each pulse, enhancing the penetration of topicals into the skin by 67% for maximum results.

“We’re constantly challenging ourselves to drive innovation forward and deliver differentiated technologies that allow our customers to provide better, more customizable treatments for their patients,” said Todd Tillemans, Chief Executive Officer of Cynosure. “The Fusion Tip is the first and only RF microneedling tip on the market designed to enhance the penetration of topicals deeper into the dermis, improving the quality of your skin. This is a real game changer for RF microneedling and we’re proud to be at the forefront of this next-level technology.”

The Fusion Tip is the latest addition to Cynosure’s Potenza system, the world’s first 4-mode RF microneedling device, which uses ultrafine needles and radiofrequency energy to penetrate the top layer of the skin, triggering the body’s natural healing process to regenerate new collagen and elastin. Unlike other treatments on the market, Potenza treatments can be performed on all skin types, anywhere on the body and any time of year. Now with the single-use, disposable Fusion Tip, practitioners can maximize topical penetration while tightening the skin through soft tissue coagulation, revolutionizing the standard microneedling treatment.

“Potenza’s new Fusion Tip enables me to confidently deliver topicals deeper in the dermis, allowing me to reach where it matters most,” said Dr. Deanne Mraz Robinson of Modern Dermatology in Westport, CT. “By enhancing the penetration of topicals into the skin, I am able to maximize patient results.”

Of the Potenza system’s four modes (monopolar or bipolar, delivered at either 1 MHz or 2 MHz frequency), the Fusion Tip operates in monopolar at 1 MHz for deep and wide RF delivery and enhanced tissue engagement and topical penetration. While three to five treatments at roughly four to six weeks apart are recommended, patients may notice improvements in their skin after the first or second treatment and will continue to see improvements six to 12 months post-treatment.

The Fusion Tip is commercially available in the U.S. and only compatible with Cynosure’s Potenza device.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles